Folate Deficiency in Seniors May Increase Dementia, Mortality Risks

THURSDAY, March 17, 2022 (HealthDay News) -- The presence of serum folate deficiency is associated with dementia and all-cause mortality among older adults, although there is evidence of reverse causation, according to a study published online March 15 in Evidence-Based Mental Health.
Anat Rotstein, Ph.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined the associations between serum folate deficiency and the risks for incident dementia and all-cause mortality among a cohort of 27,188 adults aged 60 to 75 years without preexisting dementia.
The researchers found that compared with its absence, the presence of serum folate deficiency (<4.4 ng/mL) was associated with an increased risk for dementia and all-cause mortality (hazard ratios, 1.68 and 2.98, respectively). Moderate and mild evidence was seen for reverse causation for dementia and all-cause mortality, respectively.
"Serum concentrations of folate may function as a biomarker used to modify the risks of dementia and mortality in old age," the authors write. "The implications for public health policy appear to be to reliably monitor serum concentrations of folate in older adults and treat deficiency for preventative measures and/or as part of implemented therapeutic strategies while regularly reviewing patients' clinical outcomes."
Related Posts
Medicare ahorrará miles de millones a EE. UU. al negociar los precios de los medicamentos
LUNES, 30 de enero de 2023 (HealthDay News) -- El gobierno de EE. UU. podría...
Twelfth Version of Living Guideline Issued for Drugs for COVID-19
FRIDAY, Sept. 16, 2022 (HealthDay News) -- In the living guideline developed by...
Health Highlights: Oct. 1, 2021
Merck to seek emergency approval for its new COVID antiviral pill: In a trial of...
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
TUESDAY, Dec. 6, 2022 (HealthDay News) -- The U.S. Food and Drug Administration...